The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

M.V. Budzinskaia

FGBU "Nauchno-issledovatel'skiĭ institut glaznykh bolezneĭ" RAMN, Moskva

T.V. Pogoda

Research Center of Neurology, Moscow, Russia

E.V. Generozov

Sechenov First Moscow State Medical University of Healthcare Ministry of the Russia, Moscow, Russia, Federal Research Clinical Center for Physico-Chemical Medicine, FMBA of Russia, Moscow, Russia

E.A. Chikun

FGBU "Nauchno-issledovatel'skiĭ institut glaznykh bolezneĭ" RAMN, Moskva

I.V. Gurova

FGBU "Nauchno-issledovatel'skiĭ institut glaznykh bolezneĭ" RAMN, Moskva

I.V. Shchegoleva

FGBU "Nauchno-issledovatel'skiĭ institut glaznykh bolezneĭ" RAMN, Moskva

M.V. Sizova

FGBU "NII glaznykh bolezneĭ" RAMN

Contemporary pharmacogenetic approaches to the treatment of age-related macular degeneration

Authors:

M.V. Budzinskaia, T.V. Pogoda, E.V. Generozov, E.A. Chikun, I.V. Gurova, I.V. Shchegoleva, M.V. Sizova

More about the authors

Journal: Russian Annals of Ophthalmology. 2013;129(5): 127‑135

Views: 409

Downloaded: 14

To cite this article:

Budzinskaia MV, Pogoda TV, Generozov EV, Chikun EA, Gurova IV, Shchegoleva IV, Sizova MV. Contemporary pharmacogenetic approaches to the treatment of age-related macular degeneration. Russian Annals of Ophthalmology. 2013;129(5):127‑135. (In Russ.)

Recommended articles:
Fari­cimab: from research to clinical practice. Russian Annals of Ophthalmology. 2023;(4):115-120

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.